Clinical Trials Logo

Clinical Trial Summary

The CarMA (Carbon Monoxide and Altitude) Study aims to observe the vascular effects of carbon monoxide exposure at low and high altitudes.


Clinical Trial Description

Each year, millions of people make journeys from low altitude regions to high altitude for recreation, travel, and religious pilgrimage. Carbon monoxide (CO) is commonly associated with cigarette smoke, exhaust fumes, and is viewed as a life-threatening toxic gas. Exposure to CO occurs during travel to and during activities common in high-altitude travel and pilgrimage including vehicle fumes, incense, and second-hand smoke exposure. High altitude exposure and CO exposure have been observed independently to have complex and opposing effects on vascular endothelial function. Observation of these stimuli together in a controlled environment may allow for further understanding of the underlying mechanisms of vascular physiology and adaptations to both high-altitude and CO exposure. The CarMA (Carbon Monoxide and Altitude) Study aims to observe the vascular effects of carbon monoxide exposure at low and high altitudes. Recently, other studies have showed a significant improvement in flow mediated dilation (FMD) with acute exposure to low levels of CO To date, no research has been presented concerning the effect of CO on vascular function at altitude. The present study aims to observe the effect of acute carbon monoxide exposure on 1) flow mediated dilation, 2) conduit artery flow in exercise induced reactive hyperemia at sea level and at altitude, and 3) the effect of CO on vascular function in a high altitude dwelling (sherpa) population. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04928183
Study type Interventional
Source University of Alberta
Contact
Status Completed
Phase N/A
Start date June 10, 2021
Completion date May 18, 2022

See also
  Status Clinical Trial Phase
Completed NCT03680638 - The Effect of Antioxidants on Skin Blood Flow During Local Heating Phase 1
Recruiting NCT05997732 - Sympathetic Neurovascular Transduction: Role of Adrenergic Receptors and Sex Differences Phase 4
Recruiting NCT06117007 - Effects of Betalains on Cardiovascular Health and Quality of Life N/A
Active, not recruiting NCT03659864 - The Role of Eicosanoids in the Cardiovascular Actions of Inhaled Nanoparticles N/A
Completed NCT03459027 - Nitrate Supplementation and Muscle Blood Flow N/A
Recruiting NCT04255160 - Impact of Estradiol on Endothelial Function in Peri-Menopausal Women Phase 4
Recruiting NCT05522075 - Reducing Blood Pressure in Mid-life Adult Binge Drinkers N/A
Completed NCT00184886 - The Influence of Methotrexate on the Metabolism and Vascular Effects of Adenosine in Humans N/A
Completed NCT02292342 - An Investigation of the Dose-dependent Vascualr Effects of (-)-Epicatechin in Healthy Men Phase 0
Completed NCT02095873 - Healthy Aging Through Functional Food Phase 1/Phase 2
Completed NCT00901745 - Interaction of Apelin and Angiotensin in the Human Forearm Circulation N/A
Not yet recruiting NCT06290713 - Vasodilator and Exercise Study for DMD (VASO-REx) Phase 2
Completed NCT02265107 - Effects of Exercise Training on Vascular Endothelial Function of Patients Submitted to Coronary Artery Bypass Graft N/A
Recruiting NCT05219799 - Sex Disparities in Hypoxic Vasodilation and Impact of Obesity Early Phase 1
Completed NCT03622060 - Intraarterial Nitroglycerin Versus Nicardipine and Radial Artery Occlusion Phase 3
Completed NCT01618071 - Vascular Effects of Triglyceride-rich Lipoproteins N/A
Completed NCT03190304 - The Effect of Neprilysin (LCZ696) on Exercise Tolerance in Patients With Heart Failure Phase 4
Suspended NCT04001647 - Targeting ER Stress in Vascular Dysfunction Early Phase 1
Completed NCT05525416 - Sex Differences in Sympathetic Vascular Reactivity at High Altitude N/A
Completed NCT03605095 - Evidence of Spreading Vasodilation in Human Gingiva N/A